GNMSF:OTCMKTS
Genmab A/S
၃၆၇.၀၀ US$
၀.၀၀%
(၀.၀၀) 1D
အောက် ၉, GMT-၄ ၁၀:၂၈:၃၆ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GNMSF...
Mkt. cap
ဋေ ၂.၃၂ ထ
Avg. vol.
၁.၃၇ ထောင်
Volume
၀.၀၀
52-wk high
၃၉၆.၉၇ US$
52-wk low
၂၃၂.၅၀ US$
Beta
၀.၇၃
Shares outstanding
၆.၂၄ ကုဋေ
No. of employees
၃ ထောင်
Mkt. cap
ဋေ ၂.၃၂ ထ
Avg. vol.
၁.၃၇ ထောင်
Volume
၀.၀၀
52-wk high
၃၉၆.၉၇ US$
52-wk low
၂၃၂.၅၀ US$
Beta
၀.၇၃
Shares outstanding
၆.၂၄ ကုဋေ
No. of employees
၃ ထောင်
News stories
From web sources and news partners
TipRanks
·
ပြီးခဲ့သည့် ၁ ရက်
Genmab Reports USD 4.2 Billion in Q3 2026 DARZALEX Net Sales
https://www.dars.gov.et/
·
ပြီးခဲ့သည့် ၂ ပတ်
GMAB Q2 2026 Earnings: EPS Beats Consensus by 36.6% as Shares Edge Higher - Revenue Inflection Point
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
About Genmab A/S
CEOJan G. J. van de Winkel
Employees၃.၁၂ ထောင်
Founded၁၉၉၈ ဇွန် ၁၁
Headquarters-
Sector-
Websitegenmab.com